Eisai’s DAYVIGO gets approval in Japan to treat insomnia

Japan |  News | 0 Comment | 28 Jan, 2020

Japanese firm Eisai Co., Ltd has obtained the manufacturing and marketing approval in Japan for its in-house discovered orexin receptor antagonist DAYVIGOTM (2.5mg, 5mg, and 10mg table...Read more

Sasakawa Health Foundation focuses on World Leprosy Day 2020

Japan |  News | 0 Comment | 25 Jan, 2020

Sasakawa Health Foundation has announced the start of its first-ever social media campaign with organizations of persons affected by leprosy. Taking part are 17 people's organizations in 1...Read more

Amgen Astellas Biopharma to become wholly owned Amgen affiliate

Japan |  News | 0 Comment | 28 Jan, 2020

Amgen, Astellas Pharma and Amgen Astellas BioPharma K.K. announced that on April 1, 2020, Amgen will purchase the 49% of shares in Amgen Astellas BioPharma that are held by Astellas, based ...Read more

Eisai gets approval of anti-epileptic drug in Japan

Japan |  News | 0 Comment | 27 Jan, 2020

Japanese firm Eisai Co., Ltd. has obtained the approvals of supplementary new drug applications in Japan for its in-house developed antiepileptic drug (AED) Fycompa (perampanel) for an addi...Read more

Japan Ministry approves Propess for cervical ripening

Japan |  News | 0 Comment | 23 Jan, 2020

Swiss firm Ferring Pharmaceuticals has announced that Propess® (dinoprostone) has been approved by the Minister of Health, Labour and Welfare (MHLW) in Japan for initiation of cerv...Read more

Poxel appoints industry leader Dr. David E. Moller as CSO

Japan |  News | 0 Comment | 23 Jan, 2020

POXEL, headquartered France, and with subsidiaries in Japan, is a biopharmaceutical company focused on the development of innovative treatments for metabolic disorders, including type 2 dia...Read more

Darolutamide gets marketing authorization in Japan

Japan |  News | 0 Comment | 24 Jan, 2020

The Japanese Ministry of Health, Labor and Welfare (MHLW) has granted marketing authorization for darolutamide, under the brand name Nubeqa®, for the treatment of men with non-metastati...Read more

Takeda announces liquidation of holding company

Japan |  News | 0 Comment | 22 Jan, 2020

Takeda Pharmaceutical Company Limited, headquartered in Japan, is a value-based research-driven biopharmaceutical leader dedicated to bringing Better Health and a Brighter Future to patient...Read more

Hitachi Chemical inks pact with Ori Biotech

Japan |  News | 0 Comment | 23 Jan, 2020

Hitachi Chemical Advanced Therapeutics Solutions, LLC,  a US subsidiary of Japanese firm Hitachi Chemical Co., Ltd. that engages in contract manufacturing and manufacturing development...Read more

PhoreMost, Otsuka collaborate for multi drug discovery projects

Japan |  News | 0 Comment | 22 Jan, 2020

PhoreMost Limited, the UK-based biopharmaceutical company dedicated to drugging ‘undruggable’ disease targets, has entered into a multi-project collaboration with Japan's Otsuka...Read more

ViiV Healthcare wins Japanese approval for Dovato to treat HIV-1

Japan |  News | 0 Comment | 20 Jan, 2020

ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer Inc. and Shionogi Limited as shareholders, announced that it has obtained approval of Dovato (dolutegra...Read more

Astellas completes acquisition of Audentes Therapeutics

Japan |  News | 0 Comment | 20 Jan, 2020

Japan based Astellas Pharma Inc. has successfully completed the previously announced acquisition of Audentes Therapeutics, Inc. (“Audentes”), through a tender offer by its indir...Read more

Astellas invests ¥10B to build new manufacturing facility

Japan |  News | 0 Comment | 21 Jan, 2020

Japan based Astellas Pharma Inc. has announced that the Third Fermentation Building (provisional name) will be constructed as a new manufacturing facility for active pharmaceutical ingredie...Read more

Charles River inks scientific collaboration with Takeda

Japan |  News | 0 Comment | 16 Jan, 2020

US based company Charles River has announced a multi-year drug discovery collaboration with Japanese firm Takeda Pharmaceutical Company Limited. Together, Charles River and Takeda will laun...Read more

Astellas, Adaptimmune to develop CAR-T & TCR T-cell therapies

Japan |  News | 0 Comment | 17 Jan, 2020

Japan based Astellas Pharma Inc., through its wholly-owned subsidiary Universal Cells, Inc. and Adaptimmune Therapeutics plc, a leader in cell therapy to treat cancer, have announced that t...Read more

ASKA, KinoPharma unite to treat cervical dysplasia

Japan |  News | 0 Comment | 16 Jan, 2020

ASKA Pharmaceutical Co., Ltd. and KinoPharma, Inc., both based in Tokyo, announced that they have entered into an option agreement for an exclusive license for the development and...Read more

Hitachi starts commercial manufacturing of Zynteglo

Japan |  News | 0 Comment | 15 Jan, 2020

apceth Biopharma GmbH, a subsidiary of Japan headquartered Hitachi Chemical Co., Ltd. and a leading company for the manufacturing of cell and gene therapeutics, starts the commercial manufa...Read more

ERS Genomics licenses CRISPR gene editing technology to Daiichi Sankyo

Japan |  News | 0 Comment | 14 Jan, 2020

ERS Genomics Limited, which was formed to provide broad access to the foundational CRISPR/Cas9 intellectual property co-owned by Dr. Emmanuelle Charpentier, has announced the signing of a l...Read more